Molina Healthcare CEO gifts 6,500 trust-held shares

Available on EDGAR 11/13/2026 - 05:40 PM EST Accepted by SEC EDGAR 11/13/2026 - 05:40 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Molina Healthcare, Inc. (MOH) President & CEO Joseph M. Zubretsky reported an indirect gift disposition of 6,500 common shares held by a trust to a charitable donor-advised fund on November 13, 2026; no price applies to the gift. The trust-held position afterward was 279,976 shares, while Zubretsky directly held 86,989 shares. The trust-held amount reflects an exempt transfer of 12,026 shares to Joseph M. Zubretsky Revocable Trust.

Insider Trade Summary

6,500 shares gifted

Gift 1 txn

Insider Zubretsky Joseph M

Role President & CEO

Type	Security	Shares	Price	Value
Gift	Common Stock F1, F2, F3	6,500	$0.00	$0.00
Holding	Common Stock F4	--	--	--

Holdings After Transaction: Common Stock — 279,976 shares (Indirect, Held by Trust); Common Stock — 86,989 shares (Direct)

Holdings Before and After: Common Stock, 286,476 to 279,976 shares (Indirect, Held by Trust)

Footnotes (4)

1. F1. Reflects the gift of common stock to a charitable donor advised fund.
2. F2. Price not applicable to gift.
3. F3. Reflects a transfer of 12,026 shares of common stock to Joseph M. Zubretsky Revocable Trust that was exempt from reporting.
4. F4. The shares shall vest as follows: 35,214 shares on March 1, 2027; 29,636 shares on March 1, 2028; and 22,139 shares on March 1, 2029.

Key Figures

Gift disposition: 6,500 shares Trust-held shares after transaction: 279,976 shares Directly held shares: 86,989 shares +4 more

7 metrics

Gift disposition 6,500 shares Common shares transferred to a charitable donor-advised fund on November 13, 2026

Trust-held shares after transaction 279,976 shares Indirectly held; amount reflects a transfer of 12,026 shares to Joseph M. Zubretsky Revocable Trust that was exempt from reporting

Directly held shares 86,989 shares Shares with vesting dates in 2027, 2028 and 2029

Exempt trust transfer 12,026 shares Transfer to Joseph M. Zubretsky Revocable Trust

Shares scheduled to vest March 1, 2027 35,214 shares Directly held shares

Shares scheduled to vest March 1, 2028 29,636 shares Directly held shares

Shares scheduled to vest March 1, 2029 22,139 shares Directly held shares

Key Terms

donor advised fund

1 terms

donor advised fund financial

"gift of common stock to a charitable donor advised fund"

A donor advised fund is a charitable savings account you fund with cash or assets (including stocks) that lets you take an immediate tax benefit while recommending when and which charities receive grants over time. Think of it like a dedicated piggy bank for giving: you get tax relief when you put money in, can avoid selling appreciated securities and triggering capital gains, and still control the timing and recipients of donations, which affects tax planning, portfolio decisions, and public giving signals.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many MOH shares were transferred as a gift on November 13, 2026?

A trust-held position associated with Joseph M. Zubretsky transferred 6,500 common shares as a gift to a charitable donor-advised fund.

What is the vesting schedule for Joseph M. Zubretsky's directly held MOH shares?

The directly held shares are scheduled to vest as follows: 35,214 shares on March 1, 2027; 29,636 shares on March 1, 2028; and 22,139 shares on March 1, 2029.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Zubretsky Joseph M

(Last) (First) (Middle)

2180 HARVARD STREET

SUITE 400

(Street)

SACRAMENTO CALIFORNIA 95815

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MOLINA HEALTHCARE, INC. [ MOH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President & CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/13/2026		G(1)		6,500	D	$0(2)	279,976(3)	I	Held by Trust
Common Stock								86,989(4)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects the gift of common stock to a charitable donor advised fund.

2. Price not applicable to gift.

3. Reflects a transfer of 12,026 shares of common stock to Joseph M. Zubretsky Revocable Trust that was exempt from reporting.

4. The shares shall vest as follows: 35,214 shares on March 1, 2027; 29,636 shares on March 1, 2028; and 22,139 shares on March 1, 2029.

Remarks:

	Jeff D. Barlow, by power of attorney for Joseph M. Zubretsky	11/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)